Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 9
Submit an article Journal homepage
495
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Focus issue on cardiomyopathies

Patrizio Lancellottia Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium;b Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, ItalyCorrespondence[email protected]
,
Hélène Petitjeana Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium
,
Nils de Marneffea Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium
&
Bernard Cosynsc Centrum Voor Harten Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium;d In vivo Cellular and Molecular Imaging (ICMI) Center, Vrije Universiteit Brussel (VUB), Brussels, Belgium
Pages 765-767 | Published online: 10 Jan 2023

References

  • Alexandre Unger A, Unger P, Mottale R, et al. Sarcoidosis presenting as acute pericarditis. A case report and review of pericardial sarcoidosis. Acta Cardiologica. 2022;77:676–682.
  • Lancellotti P, Cosyns B. Focus issue on diagnostic work-up and prognostic assessment in cardiac disease. Acta Cardiologica. 2022;77:671–672.
  • Bazoukis G, Liatakis I, Vassiliou VS, et al. The role of late gadolinium enhancement in predicting arrhythmic events in cardiac sarcoidosis patients – a mini-review. Acta Cardiologica. 2022;77:768–773.
  • Solmaz H, Ozdogan O. Left atrial phasic volumes and functions changes in asymptomatic patients with sarcoidosis: evaluation by three-dimensional echocardiography. Acta Cardiologica. 2022;77:782–790.
  • Andreoli C, Biscottini E, Savarese G, et al. The challenging management of cardiac involvement in systemic sarcoidosis. Acta Cardiologica. 2022;77:846–847.
  • de Marneffe N, Dulgheru R, Ancion A, et al. Cardiac amyloidosis: a review of the literature. Acta Cardiologica. 2022:683–692.
  • Debonnaire P, Claeys M, De Smet M, et al. Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications. Acta Cardiologica. 2022;77:791–804.
  • Kis M, Dogan Y, Yildirim A, LVH-TR Study Collaborates, et al. Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in turkish population (LVH-TR). Acta Cardiologica. 2022;77:836–845.
  • Huang H, He H, Qin Y, et al. Independent prognostic value of left ventricular mass index in patients with light-chain amyloidosis. Acta Cardiologica. 2022;77:815–821.
  • Sade E, Akdogan A. Myocardial strain: speckle tracking or early disease tracking? Acta Cardiologica. 2022;77:859–860.
  • Sunbul M, Midi IP, Agackiran SK, et al. Myocardial involvement in behçet’s disease may be higher in patients with Neuro-Behçet’s disease: a speckle tracking echocardiographic study. Acta Cardiol. 2022;77:515–523.
  • Kopeva K, Grakova EV, Shilov SN, et al. Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors. Acta Cardiologica. 2022;77:805–814.
  • Konsek-Komorowska SJ, Cygański P, Rynkiewicz A. Takotsubo cardiomyopathy triggered by a single dose of flecainide in patient with focal atrial tachycardia. Acta Cardiologica. 2022;77:848–851.
  • Van Kerkhove O, Renders F, Leys M. A case of myocarditis following ChAdOx1 nCov-19 vaccination. Acta Cardiologica. 2022;77:852–854.
  • Ojha V, Nagulakonda S, Malhi AS, et al. Advanced cardiac MRI to detect myocarditis after COVID-19 vaccination in a 22-year-old man. Acta Cardiologica. 2022;77:855–856.
  • Song Y, Zhang Y, Zhang X, et al. AMPK/Sirt1-mediated inflammation is positively correlated with myocardial fibrosis during ageing. Acta Cardiologica. 2022;77:826–835.
  • De Turck L, Sarens T, Veldeman L, et al. For the love of muscles: a bodybuilder with complicated left ventricular heart failure. Acta Cardiologica. 2022:774–777.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.